Literature DB >> 27004420

Introduction to small renal tumours and prognostic indicators.

Alessandro Crestani1, Marta Rossanese1, Mattia Calandriello1, Stefano Sioletic2, Gianluca Giannarini1, Vincenzo Ficarra3.   

Abstract

Over the past years, the widespread use of radiological imaging for evaluating abdominal symptoms unrelated to kidney cancer has been linked to a significant increase in the percentage of renal tumours incidentally detected at an asymptomatic stage. The definition of 'small' renal tumours has changed over the years. Presently, according to dimensional criteria, surgical indications and prognostic impact, small renal tumours are defined as masses ≤4 cm in size. Classical preoperative variables that influence the decision-making process in the management of T1a renal tumours can be classified as patient-related and tumour-related factors. Age is an independent predictor of cancer-specific survival (CSS), with older patients exhibiting significantly worse survival. An accurate classification of the anatomical and topographical characteristics of small renal masses based on available nephrometry systems is necessary for standard preoperative evaluation of patients eligible for partial nephrectomy (PN). Renal tumour biopsies (RTBs) can be indicated in patients eligible for active surveillance or ablative treatments, those with other primary tumours, those with prior renal lesions and/or those with multiple synchronous tumours, showing a median diagnostic rate of 92%. Small renal tumours typically have a good prognosis. Patient age, mode of presentation, nuclear grading, coagulative necrosis and histologic subtype can influence the prognosis of this subgroup of RCC.
Copyright © 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Kidney cancer; Partial nephrectomy; Renal cancer; Small renal tumours

Mesh:

Year:  2016        PMID: 27004420     DOI: 10.1016/j.ijsu.2016.03.038

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

Review 1.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

2.  Skin-to-tumor Distance Predicts Treatment Failure of T1A Renal Cell Carcinoma Following Percutaneous Cryoablation.

Authors:  Simone L Vernez; Zhamshid Okhunov; Kamaljot Kaler; Ramy F Youssef; Rahul Dutta; Arkadiy Palvanov; Paras Shah; Kathryn Osann; David N Siegel; Igor Lobko; Louis Kavoussi; Ralph V Clayman; Jaime Landman
Journal:  Urology       Date:  2017-06-23       Impact factor: 2.649

3.  Noninvasive assessment and quantification of tumour vascularisation using MRI and CT in a tumour model with modifiable angiogenesis - An animal experimental prospective cohort study.

Authors:  M Mirus; S V Tokalov; G Wolf; J Heinold; V Prochnow; N Abolmaali
Journal:  Eur Radiol Exp       Date:  2017-10-16

4.  'Trifecta' outcomes of robot-assisted partial nephrectomy: Results of the 'low volume' surgeon.

Authors:  Cem Basatac; Haluk Akpinar
Journal:  Int Braz J Urol       Date:  2020 Nov-Dec       Impact factor: 1.541

5.  Percutaneous CT-Guided Renal Cryoablation: Technical Aspects, Safety, and Long-Term Oncological Outcomes in a Single Center.

Authors:  Stefano Cernic; Cristina Marrocchio; Riccardo Ciabattoni; Ilaria Fiorese; Fulvio Stacul; Fabiola Giudici; Michele Rizzo; Maria Assunta Cova
Journal:  Medicina (Kaunas)       Date:  2021-03-20       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.